XERIS BIOPHARMA HOLDINGS INC's ticker is and the CUSIP is 98422E103. A total of 94 filers reported holding XERIS BIOPHARMA HOLDINGS INC in Q4 2021. The put-call ratio across all filers is 0.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $177 | -99.6% | 95 | -99.4% | 0.00% | – |
| Q2 2023 | $39,572 | +273.4% | 15,104 | +89.6% | 0.00% | – |
| Q4 2022 | $10,597 | -53.9% | 7,968 | -45.6% | 0.00% | – |
| Q3 2022 | $23,000 | -8.0% | 14,646 | -8.2% | 0.00% | – |
| Q2 2022 | $25,000 | -95.5% | 15,956 | -92.6% | 0.00% | -100.0% |
| Q1 2022 | $551,000 | -39.7% | 215,246 | -31.0% | 0.01% | -44.4% |
| Q4 2021 | $914,000 | – | 311,797 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 6,039,028 | $9,421,000 | 17.72% |
| Stonepine Capital Management, LLC | 12,928,168 | $20,168,000 | 9.07% |
| SINECERA CAPITAL, LLC | 253,101 | $395,000 | 0.46% |
| NEA Management Company, LLC | 3,246,785 | $5,065,000 | 0.25% |
| DELTEC ASSET MANAGEMENT LLC | 537,926 | $839,000 | 0.21% |
| Kamunting Street Capital Management, L.P. | 75,000 | $117,000 | 0.19% |
| Alpine Global Management, LLC | 400,000 | $624,000 | 0.15% |
| ARMISTICE CAPITAL, LLC | 2,504,431 | $3,907,000 | 0.07% |
| Redmile Group, LLC | 1,046,587 | $1,633,000 | 0.06% |
| IHT Wealth Management, LLC | 335,287 | $523,000 | 0.04% |